Compare SMTI & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTI | EARN |
|---|---|---|
| Founded | 1982 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.6M | 200.3M |
| IPO Year | 2008 | 2012 |
| Metric | SMTI | EARN |
|---|---|---|
| Price | $18.40 | $4.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $41.00 | $5.38 |
| AVG Volume (30 Days) | 51.5K | ★ 570.3K |
| Earning Date | 03-24-2026 | 03-04-2026 |
| Dividend Yield | N/A | ★ 21.67% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,586,976.00 | N/A |
| Revenue This Year | $20.66 | $7.69 |
| Revenue Next Year | $13.97 | $19.57 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 32.47 | N/A |
| 52 Week Low | $18.29 | $4.31 |
| 52 Week High | $35.70 | $6.08 |
| Indicator | SMTI | EARN |
|---|---|---|
| Relative Strength Index (RSI) | 38.22 | 24.56 |
| Support Level | N/A | N/A |
| Resistance Level | $21.14 | $5.36 |
| Average True Range (ATR) | 0.96 | 0.13 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 0.00 | 1.38 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.